Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Debt Ratio of 0.16 for Q4 2025, down 86.78% year-over-year from 1.19 in Q4 2024, and down 86.78% quarter-over-quarter from 1.19 in Q4 2024.
Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Debt Ratio for 2 consecutive years, with 0.16 the latest figure, recorded in Q4 2025.
- In Q4 2025, Debt Ratio fell 86.78% year-over-year to 0.16; the TTM figure through Dec 2025 stood at 0.16 (down 86.78% YoY), while the FY2025 annual figure was 0.16, down 86.78% from the prior year.
- Debt Ratio fell to 0.16 in Q4 2025 per RGNT's latest filing, from 1.19 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.19 in Q4 2024 and bottomed at 0.16 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 0.33 |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.15 |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 0.07 |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 0.32 |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 0.05 |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 0.36 |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 0.20 |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 0.48 |
| 10 | Regentis Biomaterials | 1.20 Mn | -6.18 Mn | - | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.16 |
| Dec 31, 2024 | 1.19 |